Product
Kcentra
2 clinical trials
4 indications
Indication
End-Stage Heart DiseaseIndication
Heart FailureIndication
Vitamin K-dependent coagulation defectIndication
Bleeding RiskClinical trial
Optimized Administration of Prothrombin Complex Concentrate (PCC) vs. Standard Transfusion During/After Heart Transplantation - OPSTAHTStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Post Marketing Observational Study on Safety of BALFAXAR® vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure.Status: Not yet recruiting, Estimated PCD: 2031-12-31